OR WAIT null SECS
© 2023 MJH Life Sciences™ and Applied Clinical Trials Online. All rights reserved.
Applied Clinical Trials
London, UK, 25 March, 2015: MyMeds&Me, a leading SaaS provider of web-based adverse event and product quality capture solutions for life sciences, today announced their collaboration with Oracle Health Sciences to provide the Reportum® solution to Oracle Argus safety customers.
This collaboration allows access to the innovative Reportum® solution providing a standardised method of capturing complete Adverse Event data at source, from all reporter types. The Reportum® solution provides simple, web-based, user-friendly safety data capture at initial reporter interaction and supports direct reporting by consumers - streamlining what is often a paper-based activity that generates duplicate data entry processes, call centres - often dealing with high volumes of contacts with varying levels of experience and healthcare professionals.
For Oracle customers, the Oracle Argus pharmacovigilance platform will provide the hub for all safety and product quality data captured via the Reportum® solution. They will be able to review, manage, analyse and report all safety and product quality data consistently, irrespective of reporting route.
This combined solution will enable life science companies with Adverse Event obligations to: o Increase pharmacovigilance efficiency and reduce cost
o Deliver complete, cleaner data to regulators, faster
o Improve understanding of benefit risk profiles for pharmaceutical products
Dr. Andrew Rut, CEO at MyMeds&Me comments, “The recent ISMP report1 highlighted the scale of the issue of non-complete AE data submitted to the FDA. We believe the collaboration with Oracle Health Sciences delivers innovation to Oracle Argus Safety customers who will benefit from rapid access to complete and cleaner safety data, irrespective of reporter route, by implementing the Reportum® solution”.